A Study of Temsirolimus and Bevacizumab in Recurrent Glioblastoma Multiforme

Clinical trial NCT00800917 · COMPLETED

Trial details

NCT number: NCT00800917
Sponsor: Rigshospitalet, Denmark
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Multiforme

Start date: 2008-11-01
Primary completion: 2010-02-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.